These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36727541)

  • 1. The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: A systematic review and meta-analysis.
    Tharmaraja T; Ho JSY; Neligan A; Rajakulendran S
    Epilepsia; 2023 May; 64(5):1113-1124. PubMed ID: 36727541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies.
    Lattanzi S; Leitinger M; Rocchi C; Salvemini S; Matricardi S; Brigo F; Meletti S; Trinka E
    Eur J Neurol; 2022 Feb; 29(2):626-647. PubMed ID: 34661330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
    Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
    J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?
    Costello DJ; Kilbride RD; Cole AJ
    J Neurol Sci; 2009 Feb; 277(1-2):26-31. PubMed ID: 19013586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
    Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
    Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
    Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
    Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
    Gall CR; Jumma O; Mohanraj R
    Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset refractory status epilepticus: State of the art.
    Périn B; Szurhaj W
    Rev Neurol (Paris); 2022; 178(1-2):74-83. PubMed ID: 35031143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to FIRE NORSE: A single acronym for a heterogeneous presentation. Further information from a case series and discussion of the literature.
    Alaskar AM; Aljohani MA; Dionisio S; Asiry MA; Alqadi K
    J Neuroimmunol; 2024 Mar; 388():578298. PubMed ID: 38330780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of 92 children with new-onset refractory status epilepticus.
    Wu J; Lan X; Yan L; Hu Y; Hong S; Jiang L; Chen J
    Epilepsy Behav; 2021 Dec; 125():108413. PubMed ID: 34794014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes.
    Werbaneth K; Mausolf M; Seliger J; Le S
    Epileptic Disord; 2022 Oct; 24(5):867-876. PubMed ID: 35892128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data.
    Nabbout R; Matricardi S; De Liso P; Dulac O; Oualha M
    Front Neurol; 2023; 14():1134827. PubMed ID: 37122314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of new-onset refractory status epilepticus (NORSE) in adults.
    Suchdev K; Kupsky WJ; Mittal S; Shah AK
    Seizure; 2021 Dec; 93():95-101. PubMed ID: 34740145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable?
    Nausch E; Schaffeldt L; Tautorat I; Margraf NG; Häusler M; Kluger G; Kellinghaus C; Borzikowsky C; Laufs H; van Baalen A
    Seizure; 2022 Mar; 96():18-21. PubMed ID: 35042004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The seasonality of new-onset refractory status epilepticus (NORSE).
    Gopaul MT; Hanin A; Cespedes J; Pulluru Y; Kazazian K; van Baalen A; Gofton TE; Gaspard N; Hirsch LJ
    Epilepsia; 2023 Jun; 64(6):e112-e117. PubMed ID: 37013696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.